vinorelbine,paclitaxel,vinorelbine tartrate oral,cyclophosphamide
daehwa,pierre fabre,haihe biopharmaceuticals
['vinorelbine', 'meteora-ii', 'paclitaxel, oral', 'paclitaxel', 'cyclophosphamide', 'breast', 'medsir']
phase 2 meteora-ii trial presented by dr. shows metronomic oral vinorelbine plus cyclophosphamide and capecitabine vs paclitaxel significantly improved ttf (hr 0.61), and mpfs (11.1 vs 6.9 mo hr0.67) in pts with er+/her2- metastatic breast cancer.
#esmo22 
Bring your idea to life??Creating successful IITs & optimal drug development??Medica Scientia Innovation Research????????https://t.co/cciUf0lqpM